Prospective Phase 2 Trial of Permanent Seed Implantation Prostate Brachytherapy for Intermediate-Risk Localized Prostate Cancer: Efficacy, Toxicity, and Quality of Life Outcomes.

Prospective Phase 2 Trial of Permanent Seed Implantation Prostate Brachytherapy for Intermediate-Risk Localized Prostate Cancer: Efficacy, Toxicity, and Quality of Life Outcomes. Int J Radiat Oncol Biol Phys. 2018 02 01; 100(2):374-382.

View in: PubMed

subject areas

Adult
Aged
Aged, 80 and over
Brachytherapy
Humans
Male
Middle Aged
Prospective Studies
Prostate-Specific Antigen
Prostatic Neoplasms
Quality of Life
Risk

authors with profiles

PATRICIA TRONCOSO
JERI KIM
RAJAT J KUDCHADKER
DEBORAH A KUBAN
STEVEN JAY FRANK
SEAN ERIC MCGUIRE
KAREN HOFFMAN
WILLIAM JAMES GRABER